# Vaccination of AJCC Stage IIB, IIC, III and IV Melanoma Patients With Human and Mouse Tyrosinase DNA Vaccines

> **NCT00698100** · PHASE1 · COMPLETED · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 18 (actual)

## Conditions studied

- Melanoma
- Skin

## Interventions

- **BIOLOGICAL:** human tyrosinase
- **BIOLOGICAL:** mouse tyrosinase

## Key facts

- **NCT ID:** NCT00698100
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-06
- **Primary completion:** 2011-09
- **Final completion:** 2011-09
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2011-09-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00698100

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00698100, "Vaccination of AJCC Stage IIB, IIC, III and IV Melanoma Patients With Human and Mouse Tyrosinase DNA Vaccines". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00698100. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*